ROIV

20.56

3.56% -0.76

Vorhandelsmarkt: 20.50 -0.06 -0.29%

Roivant Sciences Ltd (ROIV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ROIV? Forum Prognose

Schlusskurs vom Vortag:

$21.32

Offen:

$21.07

24-Stunden-Volumen:

8.08M

Relative Volume:

1.01

Marktkapitalisierung:

$14.04B

Einnahmen:

$125.68M

Nettoeinkommen (Verlust:

$4.81B

KGV:

3.6389

EPS:

5.65

Netto-Cashflow:

$-781.21M

1W Leistung:

-0.05%

1M Leistung:

+26.84%

6M Leistung:

+91.08%

1J Leistung:

+72.05%

1-Tages-Spanne:

$20.54

$21.23

1-Wochen-Bereich:

$19.79

$21.35

52-Wochen-Spanne:

$8.73

$21.35

Roivant Sciences Ltd Stock (ROIV) Company Profile

Firmenname

Roivant Sciences Ltd

Sektor

Healthcare (1103)

Branche

Biotechnology (618)

Telefon

441-295-5950

Adresse

7TH FLOOR, 50 BROADWAY, LONDON

Mitarbeiter

750

Twitter

Nächster Verdiensttermin

2025-02-10

Neueste SEC-Einreichungen

ROIV's Discussions on Twitter

Vergleichen Sie ROIV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ROIV Roivant Sciences Ltd	20.56	14.83B	125.68M	4.81B	-781.21M	5.65
VRTX Vertex Pharmaceuticals Inc	434.52	110.16B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	694.99	71.65B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	453.97	59.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	891.73	54.79B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	368.36	41.77B	4.98B	69.59M	525.67M	0.5197

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-02	Eingeleitet	Citigroup	Buy
2025-07-10	Fortgesetzt	Goldman	Buy
2024-02-15	Eingeleitet	Wolfe Research	Outperform
2024-01-05	Eingeleitet	Piper Sandler	Overweight
2023-12-12	Eingeleitet	Deutsche Bank	Buy
2023-10-17	Eingeleitet	Guggenheim	Buy
2023-06-08	Eingeleitet	BofA Securities	Neutral
2022-10-27	Eingeleitet	JP Morgan	Overweight
2022-05-23	Eingeleitet	SVB Leerink	Outperform
2022-04-29	Eingeleitet	Cantor Fitzgerald	Overweight
2021-12-15	Eingeleitet	Goldman	Buy
2021-11-08	Eingeleitet	H.C. Wainwright	Buy
2021-10-28	Eingeleitet	Citigroup	Buy
2021-10-26	Eingeleitet	Cowen	Outperform
2021-10-26	Eingeleitet	Jefferies	Buy
2021-10-26	Eingeleitet	Truist	Buy

Alle ansehen

Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten

05:51 AM

Guggenheim raises Roivant Sciences stock price target to $25 on pipeline progress - Investing.com India

05:51 AM

04:44 AM

Is Roivant Sciences Ltd. (87S) stock a momentum leaderOptions Play & Low Volatility Stock Recommendations - newser.com

04:44 AM

04:11 AM

Best data tools to analyze Roivant Sciences Ltd. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com

04:11 AM

04:06 AM

How to forecast Roivant Sciences Ltd. trends using time seriesPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com

04:06 AM

04:04 AM

Can Roivant Sciences Ltd. (87S) stock survive global slowdownJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com

04:04 AM

02:26 AM

Can Roivant Sciences Ltd. (87S) stock resist broad market declinesDip Buying & Fast Gain Stock Tips - newser.com

02:26 AM

Nov 13, 2025

Real time breakdown of Roivant Sciences Ltd. stock performanceBull Run & Smart Allocation Stock Tips - newser.com

Nov 13, 2025

Roivant Sciences: Brepocitinib And Roadmap Still Underpriced (NASDAQ:ROIV) - Seeking Alpha

Nov 13, 2025

Can Roivant Sciences Ltd. rally from current levelsJobs Report & Daily Momentum Trading Reports - newser.com

Nov 13, 2025

Roivant Sciences (ROIV): Evaluating Valuation After Earnings, Pipeline Wins, and Legal Milestone - simplywall.st

Nov 13, 2025

Nov 12, 2025

Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsTrade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com

Nov 12, 2025

Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date - Markets Mojo

Nov 12, 2025

Nov 11, 2025

Citigroup Maintains Roivant Sciences (ROIV) Buy Recommendation - Nasdaq

Nov 11, 2025

Looking Into Roivant Sciences Ltd's Recent Short Interest - Benzinga

Nov 11, 2025

Roivant Sciences at Guggenheim Conference: Strategic Pipeline Focus - Investing.com India

Nov 11, 2025

Transcript : Roivant Sciences Ltd. Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference, Nov-11-2025 08 - MarketScreener

Nov 11, 2025

Roivant Sciences at Guggenheim Conference: Strategic Pipeline Focus By Investing.com - Investing.com Australia

Nov 11, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2026 Earnings Call Transcript - Insider Monkey

Nov 11, 2025

Will Roivant Sciences Ltd. stock gain from government policies2025 Trade Ideas & Daily Profit Focused Stock Screening - newser.com

Nov 11, 2025

ROIV Crosses Above Average Analyst Target - Nasdaq

Nov 11, 2025

Leerink Partners raises Roivant Sciences stock price target to $29 on model extension - Investing.com Australia

Nov 11, 2025